Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation

Hypertension

Volumn 38, Issue 1, 2001, Pages 142-146

  Dendorfer, Andreas ^a   Reißmann, Siegmund ^a   Wolfrum, Sebastian ^a   Raasch, Walter ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Angiotensin converting enzyme; Bradykinin; Kinins; Rabbits; Receptors, bradykinin

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININ DERIVATIVE; RAMIPRILAT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG POTENTIATION; ENZYME ACTIVITY; HEART PROTECTION; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR DOWN REGULATION; VENOCONSTRICTION;

EID: 0035569034     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.38.1.142     Document Type: Article

References (24)

1. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
2. Effect of bradykinin-receptor blockade on the response to angiotensin-convertingenzyme inhibitor in normotensive and hypertensive subjects
3. Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans
4. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
5. ACE inhibitor potentiation of bradykinin-induced venoconstriction
6. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: Interaction at the receptor level
7. Angiotensin 1-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation
8. 2 receptors and angiotensin I-converting enzyme in CHO cells
9. 2 kinin receptor within the plasma membrane of native endothelial cells
10. Potentiation of the vascular response to kinins by inhibition of myocardial kininases
11. 2 receptor selective agonist which is not broken down by either kininase I or kininase II
12. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase
13. Protein measurement with the folin phenol reagent
14. Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells
15. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine
16. 2-agonists with improved degradation stability
17. Structureactivity studies on bradykinin and related peptides: Agonists
18. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin
19. N-domain-specific substrate, and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE
20. 2 receptor
21. 2 bradykinin receptor by ACE inhibitors
22. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart
23. 2 receptors and angiotensin-converting enzyme from guinea pig lung membranes
24. 2 receptor in caveolae